infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 178 articles from: Finance, funding & health economics

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • WHA releases new messaging guide for Global Fund advocates

    World Hepatitis Alliance / 19 February 2021

  • Developing an HCV Investment Case for Punjab (India)

    World Hepatitis Alliance / 28 July 2020

  • Pharma sells states on ‘Netflix Model’ to wipe out hep c. but at what price?

    MedCity News / 27 October 2019

  • Louisiana is creating a drug-price revolution

    The Hill / 21 May 2019

  • Louisiana picks drug company for hepatitis C treatment plan

    San Francisco Chronicle / 27 March 2019

  • Global fund for hepatitis prepares for rollout

    Devex / 27 February 2019

  • Washington takes 'Netflix' hep C drug pricing further with winner-take-all bidding

    Fierce Pharma / 29 January 2019

  • Needle and syringe programs cost-effectively prevent hepatitis C transmission

    Eurekalert Medicine & Health / 29 January 2019

  • Hepatitis C Drugs in 2019: Price Drops and Generic Pipeline in Place

    Hepatitis Central / 16 January 2019

  • Louisiana adopts ‘Netflix’ model to pay for hepatitis C drugs

    Washington Post / 13 January 2019

← First12345...18Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
      • Access to medicines & diagnostics
      • Hepatitis C elimination
      • Models of care
      • Finance, funding & health economics
      • National policy
      • European policy
      • International policy
      • Activism and civil society
      • Pharmaceutical industry
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//